Research by HMT and others has revealed that the concentration of ethanolamine phosphate (PEA) in blood fluctuates according to the medical condition of depression, suggesting its utility as a biomarker to support depression diagnosis. HMT has developed an enzyme kit for PEA detection, and Toyobo will provide suitable enzymes such as ethanolamine phosphate lyase.

Toyobo news release, October 20, 2017